Utility of routine left ventricular ejection fraction measurement before anthracycline-based chemotherapy in patients with diffuse large b-cell lymphoma

Journal of Oncology Practice

Volumn 8, Issue 6, 2012, Pages 336-340

  Conrad, Amber L ^a   Gundrum, Jacob D ^a   McHugh, Vicki L ^a   Go, Ronald S ^a  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; OXALIPLATIN; PREDNISONE; RITUXIMAB;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CARDIOVASCULAR RISK; COMORBIDITY; CONGESTIVE HEART FAILURE; FEMALE; HEALTH CARE UTILIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; RISK REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DECISION MAKING; DOXORUBICIN; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREDNISONE; RETROSPECTIVE STUDIES; STROKE VOLUME; UNNECESSARY PROCEDURES; VENTRICULAR DYSFUNCTION, LEFT; VINCRISTINE;

EID: 84876009463     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2012.000682     Document Type: Article

References (22)

1. Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002-1006, 1993
2. Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242, 2002
3. Habermann TM, Weller EA, Morrison VA, et al: Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 24:3121-3127, 2006
4. Pfreundschuh M, Trumper L, Osterborg A, et al: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: A randomised controlled trial by the MabThera international trial (MInT) group. Lancet Oncol 7:379-391, 2006
5. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Non-Hodgkin's Lymphomas, Version 4.2011. http://www.nccn.org/index.asp
6. Klocke FJ, Baird MG, Lorell BH, et al: ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 108:1404-1418, 2003
7. Bedford Laboratories: Adriamycin. http://www.bedfordlabs.com/our- products/online-catalog/products/doxorubicin.html
8. Von Hoff DD, Layard MW, Basa P, et al: Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710-717, 1979
9. Schwartz RG, McKenzie WB, Alexander J, et al: Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy: Seven-year experience using serial radionuclide angiocardiography. Am J Med 82:1109-1118, 1987
10. Swain SM, Whaley FS, Ewer MS: Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer 97:2869-2879, 2003
11. He J, Ogden LG, Bazzano LA, et al: Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161:996-1002, 2001
12. Dreicer R, Karwal MW, Midence G, et al: The role of radionuclide angiocardiography in the treatment of patients receiving doxorubicin-based chemotherapy: A reassessment. Am J Clin Oncol 20:132-137, 1997
13. Sabel MS, Levine EG, Hurd T, et al: Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition. Am J Clin Oncol 24:425-428, 2001
14. Jeyakumar A, DiPenta J, Snow S, et al: Routine cardiac evaluation in patients with early-stage breast cancer receiving adjuvant chemotherapy. Clin Breast Cancer 12:4-9, 2012
15. Shan K, Lincoff AM, Young JB: Anthracycline-induced Cardiotoxicity. Ann Intern Med 125:47-58, 1996
16. Carlson RW: Industry "rewrites" of NCCN guidelines. J Natl Compr Canc Netw 9:257, 2011
17. The Quality Oncology Practice Initiative: Review of methodology and measures. http://qopi.asco.org/Methodology
18. Miller FH: The legal ramifications of the NCCN practice guidelines. Oncology (Williston Park) 10:35-39, 1996
19. Surveillance, Epidemiology, and End Results. http://seer.cancer.gov/
20. Centers for Medicare and Medicaid Services: Physician fee schedule. http://www.cms.gov/apps/physician-fee-schedule/
21. Choosing Wisely: An initiative of the ABIM Foundation. http://choosingwisely. org/
22. Schnipper LE, Smith TJ, Raghavan D, et al: American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: The top five list for oncology. J Clin Oncol 30:1715-1724, 2012